Buy Oxycontin OP 20 mg tablet +1-909-545-6717 is a prescription medicine used to treat moderate to severe pain. Oxycontin OP 20 mg tablet may be used alone or with other medications.

Oxycontin OP 20 mg tablet is an opioid pain medication.

It is not known if Oxycontin OP 20 mg tablet is safe and effective in children younger than 18 years of age.

What Are Side Effects of OxyContin?
Oxycontin OP 20 mg tablet may cause serious side effects including:

noisy breathing,
shallow breathing,
breathing that stops during sleep (sleep apnea),
slow heart rate or weak pulse,
light-headed feeling,
confusion,
unusual thoughts or behavior,
seizure,
nausea,
vomiting,
loss of appetite,
dizziness, and
worsening tiredness or weakness,
Get medical help right away, if you have any of the symptoms listed above.

The most common side effects of Oxycontin OP 20 mg tablet include:

drowsiness,
headache,
dizziness,
tiredness,
constipation,
stomach pain,
nausea, and
vomiting
Tell the doctor if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of Oxycontin. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

WARNING

ADDICTION, ABUSE AND MISUSE; RISK EVALUATION AND MITIGATION STRATEGY (REMS); LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; NEONATAL OPIOID WITHDRAWAL SYNDROME; CYTOCHROME P450 3A4 INTERACTION; and RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS

Addiction, Abuse, and Misuse
OXYCONTIN® exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death. Assess each patient’s risk prior to prescribing Oxycontin OP 20 mg tablet and monitor all patients regularly for the development of these behaviors and conditions [see WARNINGS AND PRECAUTIONS].

Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS):
To ensure that the benefits of opioid analgesics outweigh the risks of addiction, abuse, and misuse, the Food and Drug Administration (FDA) has required a REMS for these products [see WARNINGS AND PRECAUTIONS]. Under the requirements of the REMS, drug companies with approved opioid analgesic products must make REMS-compliant education programs available to healthcare providers. Healthcare providers are strongly encouraged to

complete a REMS-compliant education program,
counsel patients and/or their caregivers, with every prescription, on safe use, serious risks, storage, and disposal of these products,
emphasize to patients and their caregivers the importance of reading the Medication Guide every time it is provided by their pharmacist, and
consider other tools to improve patient, household, and community safety.
Life-Threatening Respiratory Depression
Serious, life-threatening, or fatal respiratory depression may occur with use of OXYCONTIN. Monitor for respiratory depression, especially during initiation of Oxycontin OP 20 mg tablet or following a dose increase. Instruct patients to swallow Oxycontin OP 20 mg tablet tablets whole; crushing, chewing, or dissolving Oxycontin OP 20 mg tablet tablets can cause rapid release and absorption of a potentially fatal dose of oxycodone [see WARNINGS AND PRECAUTIONS].

Accidental Ingestion
Accidental ingestion of even one dose of OXYCONTIN, especially by children, can result in a fatal overdose of oxycodone [see WARNINGS AND PRECAUTIONS].

Neonatal Opioid Withdrawal Syndrome
Prolonged use of Oxycontin OP 20 mg tablet during pregnancy can result in neonatal opioid withdrawal syndrome, which may be life-threatening if not recognized and treated, and requires management according to protocols developed by neonatology experts. If opioid use is required for a prolonged period in a pregnant woman, advise the patient of the risk of neonatal opioid withdrawal syndrome and ensure that appropriate treatment will be available [see WARNINGS AND PRECAUTIONS].

Cytochrome P450 3A4 Interaction
The concomitant use of Oxycontin OP 20 mg tablet with all cytochrome P450 3A4 inhibitors may result in an increase in oxycodone plasma concentrations, which could increase or prolong adverse drug effects and may cause potentially fatal respiratory depression. In addition, discontinuation of a concomitantly used cytochrome P450 3A4 inducer may result in an increase in oxycodone plasma concentration. Monitor patients receiving Oxycontin OP 20 mg tablet and any CYP3A4 inhibitor or inducer [see WARNINGS AND PRECAUTIONS , DRUG INTERACTIONS , CLINICAL PHARMACOLOGY].

Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants
Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death [see WARNINGS AND PRECAUTIONS , DRUG INTERACTIONS].

Reserve concomitant prescribing of Oxycontin OP 20 mg tablet and benzodiazepines or other CNS depressants for use in patients for whom alternative treatment options are inadequate.
Limit dosages and durations to the minimum required.
Follow patients for signs and symptoms of respiratory depression and sedation.
DESCRIPTION
OXYCONTIN® (oxycodone hydrochloride) extended-release tablets is an opioid agonist supplied in 5 mg, 15 mg, 5 mg, 5 mg, 5 mg, 5 mg, and 5 mg tablets for oral administration. The tablet strengths describe the amount of oxycodone per tablet as the hydrochloride salt. The structural formula for oxycodone hydrochloride is as follows:

OXYCONTIN® (oxycodone hydrochloride) Structural Formula Illustration
C18 H21 NO4 • HCl MW 351.83

The chemical name is 4, 5α-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one hydrochloride.

Oxycodone is a white, odorless crystalline powder derived from the opium alkaloid, thebaine. Oxycodone hydrochloride dissolves in water (1 g in 6 to 7 mL). It is slightly soluble in alcohol (octanol water partition coefficient 0.7).

The 5 mg, 15 mg, 5 mg, 5 mg, 5 mg, 5 mg and 5 mg tablets contain the following inactive ingredients: butylated hydroxytoluene (BHT), hypromellose, polyethylene glycol 400, polyethylene oxide, magnesium stearate, titanium dioxide.

The 5 mg tablets also contain hydroxypropyl cellulose.

The 15 mg tablets also contain black iron oxide, yellow iron oxide, and red iron oxide.

The 5 mg tablets also contain polysorbate 80 and red iron oxide.

The 5 mg tablets also contain polysorbate 80, red iron oxide, yellow iron oxide, and black iron oxide.

The 5 mg tablets also contain polysorbate 80 and yellow iron oxide.

The 5 mg tablets also contain polysorbate 80, red iron oxide and black iron oxide.

The 5 mg tablets also contain hydroxypropyl cellulose, yellow iron oxide and FD&C Blue #2/Indigo Carmine Aluminum Lake.

Indications
Oxycontin OP 20 mg tablet coupons
3 PHARMACIES NEAR 10025 HAVE COUPONS FOR OXAYDO (BRAND NAMES:Oxycontin OP 20 mg tablet FOR 15ML OF 5MG/5ML)
Duane ReadeDuane Reade$14.99
Est. Regular Price

$5.91
with free coupon

View Coupon
WalgreensWalgreens$14.99
Est. Regular Price

$5.91
with free coupon

View Coupon
CVS PharmacyCVS Pharmacy$14.99
Est. Regular Price

$9.72
with free coupon

View Coupon
INDICATIONS
Oxycontin OP 20 mg tablet is indicated for the management of pain severe enough to require daily, aroundthe- clock, long-term opioid treatment and for which alternative treatment options are inadequate in:

Adults; and
Opioid-tolerant pediatric patients 11 years of age and older who are already receiving and tolerate a minimum daily opioid dose of at least 5 mg oxycodone orally or its equivalent.
Limitations Of Use
Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations [see WARNINGS AND PRECAUTIONS], reserve Oxycontin OP 20 mg tablet for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.
Oxycontin OP 20 mg tablet is not indicated as an as-needed (prn) analgesic.